Table 2.
Ancillary investigations
|
Item
|
May 28
|
June 1
|
June 3
|
June 10
|
| White blood cell (× 109/L) | 0.25 | 0.51 | 12.58 | 8.76 |
| Neutrophil (%) | 8.00 | 4.00 | 60.50 | 73.70 |
| Lymphocyte (%) | 88.00 | 62.70 | 25.10 | 20.00 |
| Red blood cell (× 1012/L) | 4.48 | 3.93 | 4.23 | 4.14 |
| Hemoglobin (g/L) | 126.00 | 109.00 | 117.00 | 117.00 |
| Platelet (× 109/L) | 121.00 | 163.00 | 195.00 | 173.00 |
| C-reactive protein (mg/L) | 164.96 | 69.17 | 46.26 | 1.55 |
| Procalcitonin (ng/mL) | 16.47 | 1.94 | 0.86 | - |
| IL-6 (pg/mL) | 14.18 | - | 9.57 | - |
| IL-8 (pg/mL) | 90.13 | - | 43.15 | - |
| Alanine aminotransferase (U/L) | 44.50 | 337.20 | 154.00 | - |
| Aspartate aminotransferase (U/L) | - | 37.70 | 42.80 | - |
| γ-GT (U/L) | - | 221.00 | - | - |
| Erythrocyte sedimentation rate (mm/h) | 50.00 | 102.00 | 63.00 | 51.00 |
| Albumin (g/L) | 39.80 | 30.80 | 28.00 | 19.10 |
| Total bilirubin (umol/L) | 90.50 | 37.50 | - | 12.10 |
| Direct bilirubin (umol/L) | - | 15.10 | - | - |
| Lactate dehydrogenase (U/L) | 137.90 | - | 934.30 | - |
| Ferritin (ng/mL) | 1759.00 | > 2000 | - | - |
| Triglyceride (mmol/L) | 5.08 | - | 4.89 | - |
| Prothrombin time (s) | 18.90 | 13.40 | 14.10 | 12.70 |
| Activated partial thromboplatin time (s) | 42.60 | 30.90 | 24.80 | 24.50 |
| Fibrinogen (g/L) | 7.95 | 9.81 | 7.26 | 4.47 |
| D-Dimers (mg/L) | 1.69 | 1.83 | 2.07 | - |
| International normalized ratio | 1.51 | 1.10 | 1.15 | - |
| Total lymphocyte (M/L) | - | 320.00 | - | - |
| Total-T-lymphocyte (%) | - | 62.77 | - | - |
| Helper T cell CD4 (%) | - | 44.62 | - | - |
| Cytototoxic T cell CD8 (%) | - | 9.23 | - | - |
| CD4/CD8 ratio | - | 4.83 | - | - |
| Total lymphocyte B CD19 (%) | - | 28.70 | - | - |
| Natural killer cell (CD56 + CD16) (%) | - | 18.00 | - | - |
IL: Interleukin; γ-GT: Gamma-glutamyltransferase.